Ignite Creation Date:
2024-05-06 @ 12:52 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03868423
Status:
WITHDRAWN
Last Update Posted:
2022-02-18
First Post:
2019-02-04
Brief Title:
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Sponsor:
Sameek Roychowdhury
Organization:
Ohio State University Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-04
First Submit QC Date:
March 6 2019
Study First Post Date:
2019-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-02-18
Last Update Post Date Type:
ACTUAL